Top 5 Vendors in the Global Pre-filled Syringes Market from 2017 to 2021: Technavio

LONDON–(BUSINESS WIRE)–#ResearchTechnavio
has announced the top five leading vendors in their recent global
pre-filled syringes market 2017-2021
report. This market
research report also lists nine other prominent vendors that are
expected to impact the market during the forecast period.

Competitive vendor landscape

According to the research analysis, there is an oligopoly in the global pre-filled
market where only a few vendors such as BD,
Gerresheimer, and SCHOTT holds a large market share. But the competition
among the existing vendors is high as each one of them compete to gain a
larger market share. The companies are focusing on strategic expansions,
partnerships, acquisitions, and technological advances to expand their
market size. There is a demand-supply gap in the industry, due to which
the suppliers are ramping up their production capacities by

The pre-filled syringe manufacturers supply non-sterilized bulk
pre-filled syringes to contract fillers or pharma companies. Many of the
suppliers are packaging only glass pre-filled syringes, which have been
in use much longer than plastic pre-filled syringes. However, the trend
is now shifting towards the manufacture of plastic pre-filled syringes.

Sanofi, GlaxoSmithKline, and Pfizer are the major
buyers of pre-filled syringe that are used for the delivery of insulin,
anticoagulants, and vaccines. Many underdeveloped and developing
countries rely on developed countries to meet their demand for
pre-filled syringes. For instance, India meets most its pre-filled
syringes demand via imports from the countries such as the US and
says Ramakrishna Edupulapati, a lead analyst at Technavio
for orthopedics
and medical devices

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2
Technavio reports and get the third for free.

Technavio market research analysts identify the following key


Baxter is a healthcare company that develops, manufactures, and markets
products and technologies related to hemophilia, immune disorders,
infectious diseases, kidney diseases, trauma, and other chronic and
acute medical conditions. Its products are used by hospitals, kidney
dialysis centers, nursing homes, rehabilitation centers, and research
laboratories. It is one of the leading players in the pre-filled
syringes market and has produced 385 million pre-filled syringes since


BD is a medical technology company, which manufactures and markets a
wide range of medical devices, diabetes care, pharmaceutical,
diagnostic, and surgical systems. The company has eight major product
divisions, namely, biosciences, medication and procedural solutions,
medication management solutions, pharmaceutical systems, diabetes care,
respiratory solutions, preanalytical systems, and diagnostic systems. It
is one of the leading players in the pre-filled syringes market. Its
pre-filled syringes product portfolio includes five biologics, four
vaccines, two anticoagulants, and five small molecules.


Gerresheimer is one of the major competitors in the pre-filled syringes
market. The company has a large manufacturing capacity and provides
customization options for its syringes. The company provides its
syringes in glass and plastic materials (COP). Its syringes can be
integrated into devices like auto-injectors. It has three glass
pre-filled syringes and three plastic pre-filled syringes in its product
portfolio ranging from 0.5 ml-5.0 ml. Its syringes and pen cartridges
are used for vaccines, heparins, biotech drugs, and other applications.


SCHOTT’s pre-filled syringes portfolio includes four glass pre-filled
syringes and one plastic pre-filled syringe. Its glass pre-filled
syringe is used in applications such as vaccines, anti-thrombotic,
biotech, and special applications. Its plastic pre-filled syringe is
used for hyaluronic acid, emergency drugs, diluents, and infusion
therapy. Its pre-filled syringes are compliant with the United States
Pharmacopeial Convention (USP), European Pharmacopoeia (EP), and
Japanese Pharmacopoeia (JP) international standards.


TERUMO’s product portfolio includes PLAJEX (pre-filled syringes with
staked needle). In January 2017, it launched a new variant in its
pre-filled syringes product portfolio called PLAJEX Luer Lock with a
Threaded Closure polymer prefillable syringe. The company is known for
having produced the world’s thinnest needle NANOPASS 34 for insulin
self-injection devices. It also focuses on investing in R&D for the
development of new and innovative products.

Looking for more information on this market? Request
a free sample report

Technavio’s sample reports are free of charge and contain multiple
sections of the report including the market size and forecast, drivers,
challenges, trends, and more.

Browse Related Reports:

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team


Technavio Research
Jesse Maida
Media & Marketing Executive
+1 630 333 9501
UK: +44 208 123 1770